MATTER partners with Roche Diabetes Care to source solutions for integrated Personalized Diabetes Management

The partners unveil a startup contest to improve precision health for those living with diabetes.

Chicago, IL, November 20, 2019 — MATTER, the premier healthcare incubator and innovation hub, today announced a partnership with Roche Diabetes Care, a global leader in integrated Personalized Diabetes Management (iPDM), to host the 2019-2020 Roche Diabetes Care Innovation Contest. The contest will source solutions that improve diabetes management and provide greater insight into care planning for people living with diabetes and their healthcare providers.

“For over 40 years, and with its Accu-Chek brand, Roche Diabetes Care has been dedicated to enabling people with diabetes to live life as normal and active as possible, as well as empowering healthcare professionals to optimally manage their condition,” said Stephen Ranjan, Roche Diabetes Care Vice President of Professional and Non-Insulin Therapy Franchise.”Our current Accu-Chek products offers people with diabetes and healthcare professionals innovative products and impactful solutions for convenient, efficient and effective diabetes management. We are excited to partner with MATTER as we continuously innovate in order to further improve medical outcomes and the quality of life of people with diabetes.”

By 2045, the number of people living with diabetes is expected to increase by more than 50 percent. With the rapid growth of this population, empowering those living with diabetes to more easily manage their care is more important than ever. The 2019-2020 Roche Diabetes Care Innovation Contest hopes to accelerate such innovations by advancing solutions that help people with diabetes more precisely identify the combinations of therapies and behaviors that will improve their blood glucose control, monitor and track their diabetes management and help them implement a targeted and personalized roadmap of care.

“If we can help identify tools that equip people with diabetes with actionable insights, we could make a significant difference in their lives” said Arun Bhatia, senior director of partner engagement at MATTER. “We are excited to be working with an industry leader like Roche to engage with startups that are driving positive change in this space. Through this contest, our hope is to bring together some of the smartest minds who are passionate about solving this need.”

“We are excited to be working with an industry leader like Roche to engage with startups that are driving positive change in this space. Through this contest, our hope is to bring together some of the smartest minds who are passionate about solving this need.”

After the submission deadline, semi-finalists will be chosen to go through an incubation period at MATTER. The challenge will culminate in a final presentation day at MATTER in May, where two to five semi-finalists will receive a $5,000 cash award to further develop their solutions. The winning startup will receive $20,000 from Roche Diabetes Care, mentoring and education in the field of diabetes and people with it, and a one-year membership with MATTER.

Interested companies can learn more and apply by visiting the challenge website. Applications are due by January 10, 2020 at 11:59pm CST. Selected semi-finalists will be notified via the email indicated in their application by January 17, 2020.

About Roche Diabetes Care

Roche Diabetes Care is pioneering innovative diabetes technologies and services for more than 40 years. Being a global leader in integrated Personalized Diabetes Management, more than 5,000 employees in over 100 markets worldwide work every day to support people with diabetes and those at risk to achieve more time in their target range and experience true relief from the daily therapy routines.

Roche Diabetes Care collaborates with caregivers, healthcare providers and payers to optimally manage this complex condition and contribute to sustainable care structures. Under the brand Accu-Chek and in collaboration with partners, Roche Diabetes Care creates value by providing integrated solutions to monitor glucose levels, deliver insulin and track as well as contextualize relevant data points for a successful therapy. By establishing a leading open ecosystem, connecting devices and digital solutions, Roche Diabetes Care will enable optimal personalized diabetes management and thus improve therapy outcomes.

Since 2017, mySugr with its world-leading mobile diabetes management app and services is part of Roche Diabetes Care. For more information, please visit and

All trademarks used or mentioned in this release are protected by law.


At MATTER, we believe collaboration is the best way to improve healthcare. The MATTER collaborative includes more than 200 cutting-edge startups from around the world, working together with dozens of hospitals and health systems, universities and industry-leading companies to build the future of healthcare. Together we are accelerating innovation, advancing care and improving lives. For more information, visit and follow @MATTERhealth.